Cameron J. Sabet is a global health researcher, venture capitalist, medical journalist, and final-year MD candidate at Georgetown University School of Medicine. He is the creator and host of Cutting to the Case, an international science and leadership podcast.

Through the series, he has interviewed Shark Tank's Mark Cuban, Nobel Prize winners, NASA astronauts, healthcare multibillionaires, an African Sultan, members of Congress, U.S. ambassadors, President of the American Medical Association, Chief Medical Officer of CVS Health, and CEOs of Kaiser Permanente, Hewlett Packard (HP), and Humana, among dozens of others.

Sabet serves as Senior Staff at The Lancet Global Burden of Disease Initiative and has authored more than 150 peer-reviewed publications cited over 13,000 times with 65,000+ views. His work includes lead-author publications in Nature Reviews Chemistry, The British Medical Journal (BMJ), The Lancet, The Lancet Psychiatry, and Proceedings of the National Academy of Sciences, with two publications in press at the New England Journal of Medicine. He received Harvard University's Young Global Catalyst Award and was the 2025 IHME nominee for the National Academy of Sciences Cozzarelli Prize. He is an Academic Editor at PLOS ONE and has served as a peer reviewer for Nature, The Lancet, Annals of Internal Medicine, and The BMJ.

His medical journalism has appeared in The Washington Post, NYT, Smithsonian Magazine, Teen Vogue, and The Hill, and he co-authored The Lancet 2025 U.S. Presidential Briefing Book.

Sabet is Founding Director and Principal at Multifaceted Capital, a series-agnostic venture fund with a $23M market capitalization, and he leads healthcare and technology investments exceeding $100,000 each. He serves on the boards of Paratus Health and Niura, is Chief Strategy Officer of CardioVis alongside Harvard cardiothoracic surgeon Dr. Jacques Kpodonu, and serves as a U.S. Congressional Delegate for Virginia's 8th District, working with Congressman Don Beyer on international human rights, religious freedom, and global health policy.

He earned BA and MA degrees from the University of Pennsylvania summa cum laude (4.0 major GPA), where he studied management at Wharton and religion, completing a master's thesis on Buddhist bioethics. He also holds an MBA and an MS in Financial Management from Edinburgh Business School.